Skip to main content

Table 3 Adverse events during the follow-up period

From: Monitoring of efficacy, tolerability and safety of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial

Adverse event

AL

AS–AQ

Asthenia

4

16

Loss of appetite

2

2

Diarrhoea

2

0

Vomiting

1

2

Nausea

0

1

Dizziness

0

1

Hospitalizationa

0

3

  1. aPneumonia, severe anaemia, and rhinotracheitis
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us